Articles related to Internal Medicine

According to research, there are numerous lesser-known supplements made from naturally occurring ingredients that boast health benefits. With only 10% of the plants from the total of natural resources for medicine investigated for therapeutic potential, many are not aware that these natural products offer potential health benefits. Here are five worth considering for their evidence-based advantages.

This article presents a review and commentary of selected presentations from the all-virtual 62nd American Society of Hematology (ASH) Meeting and Exposition, which took place in December 2020. Coverage includes safety and efficacy results from various trials and studies, including MEDALIST, DACOTA, P-2001, M15-531, ACE-536-MF-001, Sintra-REV, and COMMANDS.

These evidence-based guidelines of the American Society of Hematology (ASH) are intended to support patients, clinicians, and other health care professionals in their decisions about the prevention and treatment of venous thromboembolism (VTE)  – a common complication among patients with cancer who are at a markedly increased risk for morbidity and mortality.

This article presents a review and commentary of selected presentations from the all-virtual 62nd American Society of Hematology (ASH) Meeting and Exposition, which took place in December 2020. Coverage includes safety and efficacy results in trials of acalabrutinib, venetoclax, obinutuzumab, rituximab, LOXO-305, idelalisib, bendamustine, umbralisib, ublituximab, chlorambucil, lisocabtagene maraleucel, and others. 

Saving for retirement can be overwhelming with so many individual factors at play. You’ve worked hard your whole life, so why can’t you enjoy the fruits of your labor when you’re finished practicing? This article presents many things to consider when planning your financial future and details some benchmarks and metrics that will help you get on track to enjoy the golden years without worry.

A population-based longitudinal study in Korea showed relationships between high-density lipoprotein cholesterol (HDL-C) levels and variability with incident Parkinson’s disease (PD). People with a baseline HDL-C under 40 mg/dL were more likely to develop PD than those with HDL-C of 60 mg/dL or more, confirming previous findings but still questioning how variability in HDL-C may be linked to PD.